C012796 | 2-butenal | 2-butenal results in decreased expression of PRICKLE2 mRNA | 20471460 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRICKLE2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRICKLE2 mRNA" | 27188386 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of PRICKLE2 mRNA | 29067470 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of PRICKLE2 mRNA | 27153756 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased mutagenesis of PRICKLE2 gene | 25435355 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of PRICKLE2 mRNA | 21839799 |
C006780 | bisphenol A | bisphenol A affects the expression of PRICKLE2 mRNA | 21786754 |
C006780 | bisphenol A | bisphenol A results in increased expression of PRICKLE2 mRNA | 29275510 |
C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA | 28628672 |
C006780 | bisphenol A | bisphenol A affects the expression of PRICKLE2 mRNA | 21786754 |
C006780 | bisphenol A | bisphenol A results in decreased expression of PRICKLE2 mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in increased methylation of PRICKLE2 gene | 28505145 |
C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA | 28628672 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of PRICKLE2 mRNA | 21356183 |
D003042 | Cocaine | Cocaine results in increased expression of PRICKLE2 mRNA | 17898221 |
D003471 | Cuprizone | Cuprizone results in decreased expression of PRICKLE2 mRNA | 26577399 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of PRICKLE2 mRNA | 20106945|2798913 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA | 28628672 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA | 28628672 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of PRICKLE2 mRNA | 27392435 |
D002945 | Cisplatin | Cisplatin results in decreased expression of PRICKLE2 mRNA | 27392435 |
D002117 | Calcitriol | Calcitriol results in decreased expression of PRICKLE2 mRNA | 16002434 |
C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased expression of PRICKLE2 mRNA | 22079256 |
C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRICKLE2 mRNA | 22079256 |
D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in increased expression of PRICKLE2 mRNA | 23649840 |
D005557 | Formaldehyde | Formaldehyde results in increased expression of PRICKLE2 mRNA | 23649840 |
C039281 | furan | furan results in increased methylation of PRICKLE2 gene | 22079235 |
D017313 | Fenretinide | Fenretinide results in increased expression of PRICKLE2 mRNA | 28973697 |
D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA | 28628672 |
D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA | 28628672 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA | 28628672 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA | 28628672 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of PRICKLE2 mRNA | 27392435 |
C544151 | jinfukang | jinfukang results in decreased expression of PRICKLE2 mRNA | 27392435 |
D007854 | Lead | Lead affects the expression of PRICKLE2 mRNA | 28903495 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased methylation of PRICKLE2 gene | 21212295 |
D008070 | Lipopolysaccharides | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PRICKLE2 gene | 21212295 |
D008070 | Lipopolysaccharides | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of PRICKLE2 gene | 21212295 |
D008748 | Methylcholanthrene | Methylcholanthrene results in decreased expression of PRICKLE2 mRNA | 20713471 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of PRICKLE2 mRNA | 23649840 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of PRICKLE2 mRNA" | 25554681 |
C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in increased expression of PRICKLE2 mRNA | 25729387 |
C030110 | oxaliplatin | oxaliplatin results in increased expression of PRICKLE2 mRNA | 25729387 |
D052638 | Particulate Matter | Particulate Matter results in decreased expression of PRICKLE2 mRNA | 22178795 |
D010634 | Phenobarbital | Phenobarbital affects the methylation of PRICKLE2 gene | 19233941 |
D010634 | Phenobarbital | Phenobarbital affects the methylation of PRICKLE2 promoter | 19482888 |
D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRICKLE2 mRNA" | 27188386 |
D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of PRICKLE2 mRNA | 26272509 |
C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRICKLE2 mRNA | 22079256 |
C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of PRICKLE2 mRNA | 22079256|2271453 |
D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of PRICKLE2 mRNA | 23608068 |
D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of PRICKLE2 mRNA | 19162173 |
D011441 | Propylthiouracil | Propylthiouracil results in increased expression of PRICKLE2 mRNA | 24780913 |
C513635 | S-2-pentyl-4-pentynoic hydroxamic acid | S-2-pentyl-4-pentynoic hydroxamic acid results in increased expression of PRICKLE2 mRNA | 21427059 |
D012643 | Selenium | Selenium results in decreased methylation of PRICKLE2 gene | 21606628 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of PRICKLE2 mRNA | 25895662 |
C009277 | sodium arsenate | sodium arsenate results in increased expression of PRICKLE2 mRNA | 21795629 |
D014284 | Triiodothyronine | Triiodothyronine results in decreased expression of PRICKLE2 mRNA | 25172293 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PRICKLE2 gene | 21212295 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of PRICKLE2 gene | 21212295 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased methylation of PRICKLE2 gene | 21212295 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased methylation of PRICKLE2 gene | 21212295 |
C009495 | titanium dioxide | titanium dioxide results in decreased expression of PRICKLE2 mRNA | 23557971 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of PRICKLE2 mRNA | 28065790 |
D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in increased expression of PRICKLE2 mRNA | 25729387 |
D019772 | Topotecan | Topotecan results in increased expression of PRICKLE2 mRNA | 25729387 |
D014212 | Tretinoin | Tretinoin results in increased expression of PRICKLE2 mRNA | 20488242 |
C012589 | trichostatin A | trichostatin A results in increased expression of PRICKLE2 mRNA | 24935251 |
C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of PRICKLE2 mRNA" | 26179874 |
D014635 | Valproic Acid | Valproic Acid affects the expression of PRICKLE2 mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of PRICKLE2 mRNA | 29154799 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of PRICKLE2 mRNA | 23179753|2800136 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of PRICKLE2 mRNA | 21427059 |
D014638 | Vanadates | Vanadates results in increased expression of PRICKLE2 mRNA | 22714537 |